MIRA INFORM REPORT

 

 

Report Date :

23.01.2014

 

IDENTIFICATION DETAILS

 

Name :

A. C. SURGIPHARMA PRIVATE LIMITED 

 

 

Registered Office :

K-59, Pratap Nagar, Near Pratap Nagar-Metro Station, New Delhi – 110007

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

19.03.1993

 

 

Com. Reg. No.:

55-052682

 

 

Capital Investment / Paid-up Capital :

Rs.3.007 Millions

 

 

CIN No.:

[Company Identification No.]

U51397DL1993PTC052682

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

No. of Employees :

60 (Approximately) (Office – 50 and Branch – 10)

 


 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 199000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Profitability of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit narrowed in the quarter ended September as government measures to curb imports, especially gold, kicked in.  The current account deficit, the excess of a country’s imports of goods and services over exports, narrowed to $ 5.2 billion from $ 21 billion in the year ago period, according to provisional Reserve Bank of India data. Finance Minister P. Chidambaram said the CAD for the year will be less than $ 60 billion or 3 per cent of GDP and the latest data suggests the government may achieve the target.

 

India was ranked 94th among the world’s most corrupt nations list. Denmark and New Zealand topped as the cleanest while Somalia emerged as the most corrupt.

 

India’s services sector activity witnessed a moderate improvement in November over the previous month, even while indicating the fifth successive monthly contraction, according the HSBC survey.

 

$53 million estimated losses suffered by India due to phishing attacks during the third quarter, according to a study by RSA. India ranks fourth in the list of nations hit by phishing attacks. The US remained at the top of the charts. Phishing is the process of acquiring information such as user names, passwords and credit card details by sending e-mails disguised as official mails.

 

Rs.4080 million worth of mobile-phone-based transactions by July 2013 compared to Rs.260 million in September, 2012, according to Deloitte report. The number of transactions has shot up from 94000 to 701000.

 

India aims to earn Rs.400000 million from the bandwidth auction set for January. The merger and acquisition guidelines, cleared by a group of ministers, will be out before the auction begins so that players can make informed decisions on the auctions.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Anand Mishra

Designation :

Accounts Manager

Contact No.:

91-11-23696719

Date :

20.01.2014

 

LOCATIONS

 

Registered Office :

K-59, Pratap Nagar, Near Pratap Nagar-Metro Station, New Delhi – 110007, India

Tel. No.:

91-11-23696719

Fax No.:

Not Available

E-Mail :

dkapoorassociates@yahoo.co.in

accounts@acsurgipharma.com

Website :

http://www.acsurgipharma.com

Area :

300 sq. ft.

Location :

Owned

 

 

Branch Office :

Defense Colony, Delhi, India

Area :

200 sq. ft. (Appr.)

Location :

Rented

 

 

Branch Office :

Rudrapur, Uttrakhand, India

Area :

200 sq. ft. (Appr.)

Location :

Rented

 

 

DIRECTORS

 

(AS ON 30.09.2013)

 

Name :

Mr. Ramesh Chander

Designation :

Managing Director

Address :

10735, First Floor, Street No.12, Pratap Nagar, Andha Mughal, Delhi – 110007, India

Date of Birth/Age :

13.04.1956

Qualification :

B. Com

Date of Appointment :

19.03.1993

DIN No.:

00424319

 

 

Name :

Mr. Chetan Makhija

Designation :

Director

Address :

10735, First Floor, Street No.12, Pratap Nagar, Andha Mughal, Delhi – 110007, India

Date of Birth/Age :

21.09.1983

Qualification :

M. Com

Date of Appointment :

15.04.2002

DIN No.:

00424388

 

 

KEY EXECUTIVES

 

Name :

Mr. Anand Mishra

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 30.09.2013)

 

Names of Shareholders

 

 

No. of Shares

 

 

 

Bhupinder Kumar Kalra

 

1

Chetan Makhija

 

5040

Dhawan Ar Es and Brothers HUF

 

1

Dhawan Ar Es and Company  HUF

 

1

Dhawan Es Arg HUF

 

1

Harmeet Singh

 

1

Harmeet Singh Anand HUF

 

1

Harpreet Singh Anand HUF

 

1

Kusum Sharma

 

1

Mohan Prakash Saluja

 

1

Nava Healthcare Private Limited, India

 

1

Paramjit Singh Anand HUF

 

1

Rajiv Vij

 

1

Ramesh Chander Makhija

 

25017

Sachin Vij

 

1

Seema Kathuria

 

1

Shama Rani Vij

 

1

Sushil Kumar Vij

 

1

Sushil Kumar Vij (HUF)

 

1

 

 

 

Total

 

 

30074

 

 

(AS ON 30.09.2013)

Equity Shares Break – up

 

Category

 

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

Terms :

 

Selling :

Credit

 

 

Purchasing :

Credit

 

 

GENERAL INFORMATION

 

Suppliers :

·         Pfizer Products Private Limited

 

 

Customers :

Government Sector

 

·         Loknayak Hospital

 

 

No. of Employees :

60 (Approximately) (Office – 50 and Branch – 10)

 

 

Bankers :

·         Canara Bank

15-A, Kamla Nagar, Delhi – 110007, India

Contact No.: 91-11-23844775

 

·         State Bank of India

Partap Nagar Branch, Delhi – 110007, India

 

·         ICICI Bank Limited

·         Axis Bank Limited

 

 

Facilities :

Secured Loans

31.03.2013

31.03.2012

 

 

(Rs. In Millions)

Long Term Borrowings

 

 

Term Loans **

 

 

Canara Bank, Car Loan Secured against hypothecation of Car.

2.000

0.000

Standard Chartered Bank, Secured Against Personal Guarantee of Directors

0.000

0.659

 

 

 

Short Term Borrowings

 

 

Repayable on demands

(Canara Bank, Cash Credit account, Secured against hypothecation of Stock in Trade, book debts, personal guarantee of Directors and Collateral security of Immovable property.)

23.501

14.542

 

 

 

Term Loans

 

 

Canara Bank, Car Loan Secured against hypothecation of Car.

--

0.224

Standard Chartered Bank, Secured Against Personal Guarantee of Directors

--

0.981

Kotak Mahindra Finance Limited

Secured Against Personal Guarantee of Directors

--

0.793

 

 

 

Total

 

23.501

16.540

 

NOTE:

 

Long Term Borrowings

Additional Information : **

Terms of repayment of outstanding secured borrowings are as follows :

a) Loan amounting to Rs.2.000 Millions (31.03.2013: Rs.2.000 Millions) repayable in 36 installments maturity on 31/03/2016.

b) Loan amounting to Rs.2.000 Millions (31.03.2013: Rs.0.659 Millions) repayable in 24 installments maturity on 30/10/2013.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Dilip Kapoor and Associates

Chartered Accountants

Address :

206, Mohan Complex, H Block Market, Ashok Vihar, Phase – I, New Delhi – 110052, India 

PAN No.:

AAJFD0173G

Mobile No.:

91-9810061361/ 9811339921

Email :

dkapoorassociates@yahoo.co.in

 

 

Associates/Subsidiaries :

·         Zenika Pharma

Activities: Trader of Pharma Products

 

 

CAPITAL STRUCTURE

 

(AS ON 30.09.2013)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.100/- each

Rs.10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

30074

Equity Shares

Rs.100/- each

Rs.3.007 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

3.007

3.007

2.972

(b) Reserves & Surplus

46.656

32.001

18.728

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.035

Total Shareholders’ Funds (1)+(2)

49.663

35.008

21.735

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

15.427

22.759

23.644

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.465

0.362

0.000

Total Non-current Liabilities (3)

15.892

23.121

23.644

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

23.501

16.540

9.122

(b) Trade payables

15.160

16.798

18.807

(c) Other current liabilities

11.217

4.113

8.875

(d) Short-term provisions

7.161

6.524

2.190

Total Current Liabilities (4)

57.039

43.975

38.994

 

 

 

 

TOTAL

122.594

102.104

84.373

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

13.391

10.824

11.948

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.005

0.705

0.005

(c) Deferred tax assets (net)

0.109

0.088

0.038

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

13.505

11.617

11.991

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

9.035

9.855

9.545

(c) Trade receivables

57.359

30.028

28.385

(d) Cash and cash equivalents

12.465

1.251

2.083

(e) Short-term loans and advances

23.614

43.331

28.299

(f) Other current assets

6.616

6.022

4.070

Total Current Assets

109.089

90.487

72.382

 

 

 

 

TOTAL

122.594

102.104

84.373

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

TOTAL                                    

281.948

344.311

239.872

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

258.740

323.083

234.433

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

23.208

21.228

5.439

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

1.393

1.376

1.455

 

 

 

 

 

 

PROFIT BEFORE TAX

21.815

19.852

6.894

 

 

 

 

 

Less

TAX                                                                 

7.160

6.579

2.190

 

 

 

 

 

 

PROFIT AFTER TAX

14.655

13.273

4.704

 

 

 

 

 

 

Earnings Per Share (Rs.)

487.29

443.93

158.50

 

 

Expected Sales (2013-14): Rs.280.000 Millions

 

The above information has been parted by Mr. Anand Mishra.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

5.20

3.85

1.96

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

17.81

19.60

8.18

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.44

0.57

0.32

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.78

1.12

1.51

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.91

2.06

1.86

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report

 (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS

 

Particulars 

31.03.2013

31.03.2012

 

 

(Rs. In Millions)

Long Term Borrowings

 

 

From Share Holders

10.427

16.100

From Body Corporate

3.000

6.000

 

 

 

Total

 

13.427

22.100

 

 

BUSINESS POSITION

 

The company has earned post tax Profit of rs.14.655 Millions during the current year. The directors are hopeful of crossing Rs.16.000 Millions mark sales during the year F.Y. 2013-2014.  

 

 

TRADE REFERENCE:

 

·         Pfizer Products Private Limited

·         Loknayak Hospital

 

 

 

INDEX OF CHARGES:

 

S.

No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10418744

04/03/2013

2,000,000.00

CANARA BANK

15A, KAMLA NAGAR, DELHI, DELHI - 110007, INDIA

B72895089

2

10379790

15/09/2012

5,000,000.00

CANARA BANK

15-A, KAMLA NAGAR, DELHI, DELHI - 110007, INDIA

B59409573

3

10199460

07/01/2010

5,000,000.00

CANARA BANK

15 A, KAMALA NAGAR, DELHI, DELHI - 110007, INDIA

A78075348

4

10199464

01/02/2012 *

17,500,000.00

CANARA BANK

15-A, KAMLA NAGAR, DELHI, DELHI - 110007, INDIA

B32834525

5

10092219

26/02/2008

900,000.00

CANARA BANK

15A, KAMLA NAGAR, DELHI, DELHI - 110007, INDIA

A34334896

6

90049020

29/03/2002

319,000.00

CANARA BANK

15-A, KAMLA NAGAR, DELHI, DELHI, INDIA

-

7

90049010

10/03/2012 *

17,000,000.00

CANARA BANK

15-A, KAMLA NAGAR, DELHI, DELHI - 110007, INDIA

B37562477

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Refrigerator

·         Fan and Cooler

·         Fax

·         Typewriter

·         Air Conditioner

·         Generator

·         Office Equipment

·         Cellular Phone

·         Electric Installation

·         Telephone Instruments

·         Fire Extinguisher

·         Inverter

·         Water Cooler Machine

·         Micro Wave

·         Motor

·         Scooter

·         Motor Cycle

·         Car Polo

·         Computer

·         Furniture and Fixtures

·         Lamp

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.92

UK Pound

1

Rs.101.98

Euro

1

Rs.83.93

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Report Prepared by :

NIT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.